Live Breaking News & Updates on Lanzoni Is Research Assistant Professor

UC-MSC infusions reduce risk of death, quicken recovery time in severe COVID-19 cases
Dr. Camilo Ricordi, director of the Diabetes Research Institute (DRI) and Cell Transplant Center at the University of Miami Miller School of Medicine, and his team of international collaborators are reporting the results of a groundbreaking randomized controlled trial showing umbilical cord-derived mesenchymal stem cell (UC-MSC) infusions safely reduce risk of death and quicken time to recovery for the most severe COVID-19 patients. Dr. Ricordi s peer-reviewed paper has just been published in
STEM CELLS Translational Medicine (SCTM) January 2021.
The clinical trial, authorized by the FDA last April, was initiated by The Cure Alliance, a 501(c)(3) non-profit organization of research scientists founded ten years ago by Dr. Ricordi for scientists around the world to share knowledge and accelerate cures of all diseases. ....

United States , Miller School , University Of Miami , Arnoldi Caplan , Camilo Ricordi , Fondazione Silvio Tronchetti Provera , Giacomo Lanzoni , Emily Henderson , Shelley Ross , Diabetes Research Institute , Lanzoni Is Research Assistant Professor , National Center , University Of Miami Health System , Cure Alliance , Jackson Health System , Barilla Group , Department Of Biochemistry , Cell Transplant Center , Translational Sciences , University Of Miami Miller School Medicine , Diabetes Research Institute Foundation , Simkins Family Foundation , Case Western Reserve University , Miami Miller School , Miami Tower , Jackson Memorial Hospital ,